A phase II trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer

• Published in: Chinese medical journal Vol. 126; no. 18; pp. 3470 - 3474
• Main Authors: Yang, Lin, Song, Yan, Zhou, Ai-Ping, Qin, Qiong, Chi, Yihebali, Huang, Jing, Wang, Jin-Wan
• Format: Journal Article
• Language: English
• Published: China Department of Medical Oncology, Cancer Hospital and Institute,Chinese Academy of Medical Sciences, Beijing 100021, China 2013
• Subjects: Adult; Aged; Antineoplastic Agents - therapeutic use; Female; Humans; Male; Middle Aged; Organoplatinum Compounds - therapeutic use; Stomach Neoplasms - drug therapy; Treatment Outcome; oxaliplatin; drug therapy; stomach neoplasms; S-1

Palliative chemotherapy has been shown to have a survival benefit for patients with recurrent or metastatic gastric cancer. We conducted a Phase II trial to determine the efficacy and safety of S-1 plus oxaliplatin (SOX regimen) as first-line chemotherapy for patients with unresectable locally advan...